Search

Jeffrey S. Parkin

Examiner (ID: 2776)

Most Active Art Unit
1648
Art Unit(s)
1648, 1641, 1813, 1671
Total Applications
1731
Issued Applications
935
Pending Applications
260
Abandoned Applications
571

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11277292 [patent_doc_number] => 09493769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Yeast-based assay for measuring the functional activity of an HIV-1 protease in response to an antiviral agent' [patent_app_type] => utility [patent_app_number] => 12/504456 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 9023 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 379 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504456 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/504456
Yeast-based assay for measuring the functional activity of an HIV-1 protease in response to an antiviral agent Jul 15, 2009 Issued
Array ( [id] => 6245610 [patent_doc_number] => 20100135994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'HIV VACCINE BASED ON TARGETING MAXIMIZED GAG AND NEF TO DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/504463 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16025 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135994.pdf [firstpage_image] =>[orig_patent_app_number] => 12504463 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/504463
Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Jul 15, 2009 Issued
Array ( [id] => 6588704 [patent_doc_number] => 20100061991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Identification of therapeutic agents for HIV infection' [patent_app_type] => utility [patent_app_number] => 12/457673 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15297 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061991.pdf [firstpage_image] =>[orig_patent_app_number] => 12457673 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/457673
Identification of therapeutic agents for HIV infection Jun 17, 2009 Abandoned
Array ( [id] => 6543989 [patent_doc_number] => 20100016225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/478310 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13740 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016225.pdf [firstpage_image] =>[orig_patent_app_number] => 12478310 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/478310
CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY Jun 3, 2009 Abandoned
Array ( [id] => 5302864 [patent_doc_number] => 20090297516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'ENGINEERED LECTINS FOR VIRAL INACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/476660 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25819 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297516.pdf [firstpage_image] =>[orig_patent_app_number] => 12476660 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/476660
Engineered lectin oligomers with antiviral activity Jun 1, 2009 Issued
Array ( [id] => 6290044 [patent_doc_number] => 20100158938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Tetravalent Dengue Vaccines' [patent_app_type] => utility [patent_app_number] => 12/471962 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32796 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158938.pdf [firstpage_image] =>[orig_patent_app_number] => 12471962 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/471962
Tetravalent Dengue Vaccines May 25, 2009 Abandoned
Array ( [id] => 6588136 [patent_doc_number] => 20100291540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'CARBOHYDRATE BINDING MODULE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/464788 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4138 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291540.pdf [firstpage_image] =>[orig_patent_app_number] => 12464788 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/464788
CARBOHYDRATE BINDING MODULE AND USE THEREOF May 11, 2009 Abandoned
Array ( [id] => 8834301 [patent_doc_number] => 08450056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses' [patent_app_type] => utility [patent_app_number] => 12/434298 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9313 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434298 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/434298
Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses Apr 30, 2009 Issued
Array ( [id] => 8920688 [patent_doc_number] => 08486619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses' [patent_app_type] => utility [patent_app_number] => 12/434438 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 13956 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434438 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/434438
Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses Apr 30, 2009 Issued
Array ( [id] => 5936014 [patent_doc_number] => 20110212118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'TAT Protein for preventing or treating AIDS' [patent_app_type] => utility [patent_app_number] => 12/989165 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14478 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212118.pdf [firstpage_image] =>[orig_patent_app_number] => 12989165 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989165
Modified Tat Oyi protein with enhanced immunogenicity Apr 21, 2009 Issued
Array ( [id] => 5936014 [patent_doc_number] => 20110212118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'TAT Protein for preventing or treating AIDS' [patent_app_type] => utility [patent_app_number] => 12/989165 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14478 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212118.pdf [firstpage_image] =>[orig_patent_app_number] => 12989165 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989165
Modified Tat Oyi protein with enhanced immunogenicity Apr 21, 2009 Issued
Array ( [id] => 7487513 [patent_doc_number] => 20110236409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'OVERLAPPING PEPTIDES FROM VARIABLE ANTIGENS, T CELL POPULATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/936370 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12701 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236409.pdf [firstpage_image] =>[orig_patent_app_number] => 12936370 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/936370
OVERLAPPING PEPTIDES FROM VARIABLE ANTIGENS, T CELL POPULATIONS AND USES THEREOF Mar 29, 2009 Abandoned
Array ( [id] => 6024305 [patent_doc_number] => 20110052631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'INDUCTION OF PROLIFERATION, EFFECTOR MOLECULE EXPRESSION, AND CYTOLYTIC CAPACITY OF HIV-SPECIFIC CD8+ T CELLS' [patent_app_type] => utility [patent_app_number] => 12/934522 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15468 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052631.pdf [firstpage_image] =>[orig_patent_app_number] => 12934522 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/934522
INDUCTION OF PROLIFERATION, EFFECTOR MOLECULE EXPRESSION, AND CYTOLYTIC CAPACITY OF HIV-SPECIFIC CD8+ T CELLS Mar 24, 2009 Abandoned
Array ( [id] => 8188356 [patent_doc_number] => 08182820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens' [patent_app_type] => utility [patent_app_number] => 12/407730 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 14235 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182820.pdf [firstpage_image] =>[orig_patent_app_number] => 12407730 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/407730
Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens Mar 18, 2009 Issued
Array ( [id] => 5342395 [patent_doc_number] => 20090181045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/405086 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9687 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181045.pdf [firstpage_image] =>[orig_patent_app_number] => 12405086 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/405086
TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME Mar 15, 2009 Abandoned
Array ( [id] => 6245989 [patent_doc_number] => 20100136098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'AVIAN INFLUENZA VACCINE' [patent_app_type] => utility [patent_app_number] => 12/400269 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11981 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136098.pdf [firstpage_image] =>[orig_patent_app_number] => 12400269 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/400269
Immunogenic compositions comprising liposomes and an influenza PB2 CTL epitope obtained from the highly pathogenic H5N1 strain Mar 8, 2009 Issued
Array ( [id] => 7514933 [patent_doc_number] => 08039003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis' [patent_app_type] => utility [patent_app_number] => 12/396376 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 53366 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039003.pdf [firstpage_image] =>[orig_patent_app_number] => 12396376 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/396376
Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis Mar 1, 2009 Issued
Array ( [id] => 5479628 [patent_doc_number] => 20090202585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'TAT-BASED TOLEROGEN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/395975 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11431 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202585.pdf [firstpage_image] =>[orig_patent_app_number] => 12395975 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/395975
TAT-BASED TOLEROGEN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME Mar 1, 2009 Abandoned
Array ( [id] => 6323672 [patent_doc_number] => 20100196992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA' [patent_app_type] => utility [patent_app_number] => 12/393861 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19149 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196992.pdf [firstpage_image] =>[orig_patent_app_number] => 12393861 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/393861
Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Feb 25, 2009 Issued
Array ( [id] => 6228925 [patent_doc_number] => 20100183663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA' [patent_app_type] => utility [patent_app_number] => 12/393840 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19124 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183663.pdf [firstpage_image] =>[orig_patent_app_number] => 12393840 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/393840
Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Feb 25, 2009 Issued
Menu